Literature DB >> 29649593

Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity.

Chao Wang1, Wandi Zhu1, Yuan Luo1, Bao-Zhong Wang2.   

Abstract

The immunogenicity of subunit vaccines can be augmented by formulating them into nanoparticles. We conjugated recombinant trimetric influenza A/Aichi/2/68(H3N2) hemagglutinin (HA) onto functionalized gold nanoparticle (AuNP) surfaces in a repetitive, oriented configuration. To further improve the immunogenicity, we generated Toll-like receptor 5 (TLR5) agonist flagellin (FliC)-coupled AuNPs as particulate adjuvants. Intranasal immunizations with an AuNP-HA and AuNP-FliC particle mixture elicited strong mucosal and systemic immune responses that protected hosts against lethal influenza challenges. Compared with the AuNP-HA alone group, the addition of AuNP-FliC improved mucosal B cell responses as characterized by elevated influenza specific IgA and IgG levels in nasal, tracheal, and lung washes. AuNP-HA/AuNP-FliC also stimulated antigen-specific interferon-γ (IFN-γ)-secreting CD4+ cell proliferation and induced strong effector CD8+ T cell activation. Our results indicate that intranasal co-delivery of antigen and adjuvant-displaying AuNPs enhanced vaccine efficacy by inducing potent cellular immune responses.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adjuvant; cellular immunity; co-delivery; gold nanoparticle; mucosal vaccine

Mesh:

Substances:

Year:  2018        PMID: 29649593      PMCID: PMC6177327          DOI: 10.1016/j.nano.2018.03.007

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  51 in total

1.  The ins and outs of cross-presentation.

Authors:  Kenneth L Rock
Journal:  Nat Immunol       Date:  2003-10       Impact factor: 25.606

2.  Annual influenza vaccination affects the development of heterosubtypic immunity.

Authors:  Rogier Bodewes; Pieter L A Fraaij; Joost H C M Kreijtz; Martina M Geelhoed-Mieras; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  Vaccine       Date:  2012-05-27       Impact factor: 3.641

3.  Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy.

Authors:  Suzanne Foster; Craig L Duvall; Emily F Crownover; Allan S Hoffman; Patrick S Stayton
Journal:  Bioconjug Chem       Date:  2010-11-02       Impact factor: 4.774

4.  Biological modeling of gold nanoparticle enhanced radiotherapy for proton therapy.

Authors:  Yuting Lin; Stephen J McMahon; Harald Paganetti; Jan Schuemann
Journal:  Phys Med Biol       Date:  2015-05-08       Impact factor: 3.609

5.  Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17.

Authors:  Laura I Rutitzky; Jessica R Lopes da Rosa; Miguel J Stadecker
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

6.  Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.

Authors:  Bao-Zhong Wang; Rui Xu; Fu-Shi Quan; Sang-Moo Kang; Li Wang; Richard W Compans
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

7.  The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid).

Authors:  Michael J Heffernan; Sudhir P Kasturi; Stephen C Yang; Bali Pulendran; Niren Murthy
Journal:  Biomaterials       Date:  2008-11-25       Impact factor: 12.479

8.  Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.

Authors:  James J Moon; Heikyung Suh; Anna Bershteyn; Matthias T Stephan; Haipeng Liu; Bonnie Huang; Mashaal Sohail; Samantha Luo; Soong Ho Um; Htet Khant; Jessica T Goodwin; Jenelyn Ramos; Wah Chiu; Darrell J Irvine
Journal:  Nat Mater       Date:  2011-02-20       Impact factor: 43.841

9.  Dual-linker gold nanoparticles as adjuvanting carriers for multivalent display of recombinant influenza hemagglutinin trimers and flagellin improve the immunological responses in vivo and in vitro.

Authors:  Chao Wang; Wandi Zhu; Bao-Zhong Wang
Journal:  Int J Nanomedicine       Date:  2017-07-04

Review 10.  Applications of nanotechnology for immunology.

Authors:  Douglas M Smith; Jakub K Simon; James R Baker
Journal:  Nat Rev Immunol       Date:  2013-08       Impact factor: 53.106

View more
  30 in total

1.  Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.

Authors:  Eun-Ju Ko; Youri Lee; Young-Tae Lee; Yu-Jin Jung; Vu L Ngo; Min-Chul Kim; Ki-Hye Kim; Bao-Zhong Wang; Andrew T Gewirtz; Sang-Moo Kang
Journal:  Vaccine       Date:  2019-05-14       Impact factor: 3.641

2.  Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.

Authors:  Chunhong Dong; Bao-Zhong Wang
Journal:  Adv Nanobiomed Res       Date:  2021-12-07

Review 3.  Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.

Authors:  Vincent Lenders; Xanthippi Koutsoumpou; Ara Sargsian; Bella B Manshian
Journal:  Nanoscale Adv       Date:  2020-08-24

4.  Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains.

Authors:  Chunhong Dong; Ye Wang; Gilbert X Gonzalez; Yao Ma; Yufeng Song; Shelly Wang; Sang-Moo Kang; Richard W Compans; Bao-Zhong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

Review 5.  Nanoparticle-Based Vaccines Against Respiratory Viruses.

Authors:  Soultan Al-Halifa; Laurie Gauthier; Dominic Arpin; Steve Bourgault; Denis Archambault
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

6.  Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus.

Authors:  Avishekh Gautam; Byoung Kwon Park; Te Ha Kim; Madhav Akauliya; Dongbum Kim; Sony Maharjan; Joongwon Park; Jinsoo Kim; Hanseul Lee; Man-Seong Park; Younghee Lee; Hyung-Joo Kwon
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561

Review 7.  Nano-based approach to combat emerging viral (NIPAH virus) infection.

Authors:  Rout George Kerry; Santosh Malik; Yisehak Tsegaye Redda; Sabuj Sahoo; Jayanta Kumar Patra; Sanatan Majhi
Journal:  Nanomedicine       Date:  2019-03-21       Impact factor: 5.307

Review 8.  Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines.

Authors:  Lantian Lu; Viet Tram Duong; Ahmed O Shalash; Mariusz Skwarczynski; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2021-05-28

Review 9.  Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.

Authors:  Cynthia Calzas; Christophe Chevalier
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

Review 10.  Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.

Authors:  Lev A Dykman
Journal:  Expert Rev Vaccines       Date:  2020-04-28       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.